Digital Therapeutics (DTx) for Pain: Pilot Study of a Virtual Reality Software for Chronic Pain

NCT ID: NCT04225884

Last Updated: 2023-11-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-02-04

Study Completion Date

2023-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective, randomised, double-blind, 3-arm parallel group comparison of 2 different virtual reality softwares and standard care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prospective, randomised, double-blind, 3-arm parallel group comparison of DTx for pain (treatment A), control (treatment B) and an open standard care arm, over 6-8 weeks. An optional adaptive, multi-objective, multi-purpose, extension is included. Study devices will be delivered to the patient's home with instructions for use; patients will receive remote technical support.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Low Back Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

DTx for pain

Treatment A software

Group Type ACTIVE_COMPARATOR

DTx for pain software

Intervention Type OTHER

Software with active intervention

Control

Treatment B software

Group Type SHAM_COMPARATOR

Control software

Intervention Type OTHER

Software without active intervention

Standard care

Pain medication

Group Type OTHER

Standard care

Intervention Type OTHER

Pain medication

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

DTx for pain software

Software with active intervention

Intervention Type OTHER

Control software

Software without active intervention

Intervention Type OTHER

Standard care

Pain medication

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Competent male or female adults (age ≥ 18 years).
* Chronic low back pain
* Written informed consent
* Finnish speaking
* having a clear, flat surface of at least 2 x 2 m of size to interact with DTx for pain
* Can stoop without severe pain

Exclusion Criteria

* History of epilepsy, migraine, vertigo or psychosis
* Confirmed diagnosis of cancer
* Prone to strong motion sickness requiring treatment
* Pregnancy
* Physiotherapy based interventions contraindicated
* Severe or acute structural pathologies (e.g. spondylitis, epidural abscess, spondylolisthesis, acute herniated or ruptured disc, traumatic injury, or severe spinal stenosis) that could be worsened by the intervention as assessed by the principal investigator
* Has received (in last 2 years) or is receiving formal psychotherapy from a psychologist for pain or allied health care professional at the screening stage
* Any other condition that would affect posture or balance, and
* Prior participation in DTx for pain feasibility study or in any part of the current study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Orion Corporation, Orion Pharma

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Orion Pharma Clinical Study Director

Role: STUDY_DIRECTOR

Orion Corporation, Orion Pharma

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CPU Orion Pharma

Espoo, , Finland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Finland

References

Explore related publications, articles, or registry entries linked to this study.

Liikkanen S, Makinen M, Huttunen T, Sarapohja T, Stenfors C, Eccleston C. Body movement as a biomarker for use in chronic pain rehabilitation: An embedded analysis of an RCT of a virtual reality solution for adults with chronic pain. Front Pain Res (Lausanne). 2022 Dec 20;3:1085791. doi: 10.3389/fpain.2022.1085791. eCollection 2022.

Reference Type DERIVED
PMID: 36606032 (View on PubMed)

Eccleston C, Fisher E, Liikkanen S, Sarapohja T, Stenfors C, Jaaskelainen SK, Rice ASC, Mattila L, Blom T, Bratty JR. A prospective, double-blind, pilot, randomized, controlled trial of an "embodied" virtual reality intervention for adults with low back pain. Pain. 2022 Sep 1;163(9):1700-1715. doi: 10.1097/j.pain.0000000000002617. Epub 2022 Mar 25.

Reference Type DERIVED
PMID: 35324507 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3129002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Post-stroke Pain taVNS
NCT06456385 COMPLETED NA
Vestibular Innovation in Pain
NCT06559839 COMPLETED NA